Interferon alfa in the postsurgical management of high-risk melanoma: is it worth it?
J Clin Oncol
.
2009 Jun 20;27(18):2896-7.
doi: 10.1200/JCO.2009.22.2133.
Epub 2009 May 11.
Authors
John Glaspy
,
Antoni Ribas
,
Bartosz Chmielowski
PMID:
19433677
DOI:
10.1200/JCO.2009.22.2133
No abstract available
Publication types
Comment
Editorial
MeSH terms
Humans
Interferon-alpha / therapeutic use*
Melanoma / drug therapy*
Melanoma / surgery
Skin Neoplasms / drug therapy*
Skin Neoplasms / surgery
Substances
Interferon-alpha